Souto EB - Search Results

1

Karczewski J, Zielińska A, Staszewski R, Eder P, Dobrowolska A, Souto EB. Karczewski J, et al. Among authors: souto eb. Int J Mol Sci. 2022 May 30;23(11):6145. doi: 10.3390/ijms23116145. Int J Mol Sci. 2022. PMID: 35682824 Free PMC article. Review.

2

Optimization of linalool-loaded solid lipid nanoparticles using experimental factorial design and long-term stability studies with a new centrifugal sedimentation method.

Pereira I, Zielińska A, Ferreira NR, Silva AM, Souto EB. Pereira I, et al. Among authors: souto eb. Int J Pharm. 2018 Oct 5;549(1-2):261-270. doi: 10.1016/j.ijpharm.2018.07.068. Epub 2018 Jul 31. Int J Pharm. 2018. PMID: 30075252

3

Linseed Essential Oil - Source of Lipids as Active Ingredients for Pharmaceuticals and Nutraceuticals.

Campos JR, Severino P, Ferreira CS, Zielinska A, Santini A, Souto SB, Souto EB. Campos JR, et al. Among authors: souto sb, souto eb. Curr Med Chem. 2019;26(24):4537-4558. doi: 10.2174/0929867325666181031105603. Curr Med Chem. 2019. PMID: 30378485 Review.

4

Anti-inflammatory and anti-cancer activity of citral: Optimization of citral-loaded solid lipid nanoparticles (SLN) using experimental factorial design and LUMiSizer®.

Zielińska A, Martins-Gomes C, Ferreira NR, Silva AM, Nowak I, Souto EB. Zielińska A, et al. Among authors: souto eb. Int J Pharm. 2018 Dec 20;553(1-2):428-440. doi: 10.1016/j.ijpharm.2018.10.065. Epub 2018 Oct 29. Int J Pharm. 2018. PMID: 30385373

5

Uveal melanoma: physiopathology and new in situ-specific therapies.

Souto EB, Zielinska A, Luis M, Carbone C, Martins-Gomes C, Souto SB, Silva AM. Souto EB, et al. Among authors: souto sb. Cancer Chemother Pharmacol. 2019 Jul;84(1):15-32. doi: 10.1007/s00280-019-03860-z. Epub 2019 May 11. Cancer Chemother Pharmacol. 2019. PMID: 31079217 Review.

6

3D printing in the design of pharmaceutical dosage forms.

Souto EB, Campos JC, Filho SC, Teixeira MC, Martins-Gomes C, Zielinska A, Carbone C, Silva AM. Souto EB, et al. Pharm Dev Technol. 2019 Oct;24(8):1044-1053. doi: 10.1080/10837450.2019.1630426. Epub 2019 Jun 25. Pharm Dev Technol. 2019. PMID: 31180272

7

Development and Optimization of Alpha-Pinene-Loaded Solid Lipid Nanoparticles (SLN) Using Experimental Factorial Design and Dispersion Analysis.

Zielińska A, Ferreira NR, Durazzo A, Lucarini M, Cicero N, Mamouni SE, Silva AM, Nowak I, Santini A, Souto EB. Zielińska A, et al. Among authors: souto eb. Molecules. 2019 Jul 24;24(15):2683. doi: 10.3390/molecules24152683. Molecules. 2019. PMID: 31344802 Free PMC article.

8

Key production parameters for the development of solid lipid nanoparticles by high shear homogenization.

Souto EB, Doktorovova S, Zielinska A, Silva AM. Souto EB, et al. Pharm Dev Technol. 2019 Nov;24(9):1181-1185. doi: 10.1080/10837450.2019.1647235. Epub 2019 Aug 8. Pharm Dev Technol. 2019. PMID: 31354002

9

Nanopharmaceutics: Part I-Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU.

Souto EB, Silva GF, Dias-Ferreira J, Zielinska A, Ventura F, Durazzo A, Lucarini M, Novellino E, Santini A. Souto EB, et al. Pharmaceutics. 2020 Feb 11;12(2):146. doi: 10.3390/pharmaceutics12020146. Pharmaceutics. 2020. PMID: 32053962 Free PMC article. Review.

10

Perillaldehyde 1,2-epoxide Loaded SLN-Tailored mAb: Production, Physicochemical Characterization and In Vitro Cytotoxicity Profile in MCF-7 Cell Lines.

Souto EB, Souto SB, Zielinska A, Durazzo A, Lucarini M, Santini A, Horbańczuk OK, Atanasov AG, Marques C, Andrade LN, Silva AM, Severino P. Souto EB, et al. Among authors: souto sb. Pharmaceutics. 2020 Feb 16;12(2):161. doi: 10.3390/pharmaceutics12020161. Pharmaceutics. 2020. PMID: 32079103 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

353 results

Search Page